Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same author

Sacrospinous Hysteropexy With Mesh vs Vaginal Hysterectomy for Treatment of Uterovaginal Prolapse: 10-Year Results of a Randomized Clinical Trial.

JAMA surgery·2026
Same author

Goal Achievement in Women With Urinary Incontinence After Midurethral Sling.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Gender-Affirming Testosterone Treatment and Lower Urinary Tract Symptoms.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Urethral Morphology and Support Associated with Urinary Symptoms after Vaginal Surgery with and without Midurethral Sling.

medRxiv : the preprint server for health sciences·2026
Same author

Stool Microbiota, Metabolites, and Fecal Incontinence in Women.

Urogynecology (Philadelphia, Pa.)·2026

Related Experiment Video

Updated: Jul 7, 2026

Development of a Uterosacral Ligament Suspension Rat Model
08:58

Development of a Uterosacral Ligament Suspension Rat Model

Published on: August 17, 2022

3.9K

Apical Suspension Repair for Vaginal Vault Prolapse: A Randomized Clinical Trial.

Shawn A Menefee1, Holly E Richter2, Deborah Myers3

  • 1Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Kaiser Permanente San Diego, San Diego, California.

JAMA Surgery
|May 22, 2024
PubMed
Summary

Sacrocolpopexy and transvaginal mesh repair for vaginal vault prolapse show similar, lower failure rates than native tissue repair. All three surgical methods offer sustained benefits with low complication rates.

More Related Videos

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

5.3K
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
03:30

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy

Published on: October 25, 2024

1.4K

Related Experiment Videos

Last Updated: Jul 7, 2026

Development of a Uterosacral Ligament Suspension Rat Model
08:58

Development of a Uterosacral Ligament Suspension Rat Model

Published on: August 17, 2022

3.9K
Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse
03:43

Laparoscopic Non-Mesh Cerclage Pectopexy for Pelvic Organ Prolapse

Published on: September 13, 2022

5.3K
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
03:30

Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy

Published on: October 25, 2024

1.4K

Area of Science:

  • Urogynecology
  • Pelvic reconstructive surgery

Background:

  • Vaginal vault prolapse after hysterectomy is a common condition.
  • The optimal surgical repair method remains unclear, necessitating comparative studies.

Purpose of the Study:

  • To compare the efficacy and safety of sacrocolpopexy, transvaginal mesh, and native tissue repair for vaginal vault prolapse.

Main Methods:

  • A multisite, randomized clinical trial involving 376 women with symptomatic vaginal vault prolapse.
  • Surgical interventions included sacrocolpopexy, transvaginal mesh, and transvaginal native tissue repair.
  • Outcomes were assessed for up to 60 months, with a primary endpoint of time to composite treatment failure.

Main Results:

  • At 36 months, adjusted failure rates were 28% for sacrocolpopexy, 29% for transvaginal mesh, and 43% for native tissue repair.
  • Sacrocolpopexy demonstrated superiority over native tissue repair (P=.01).
  • Transvaginal mesh was noninferior to sacrocolpopexy and showed similar subjective outcomes with low mesh exposure and dyspareunia rates.

Conclusions:

  • Sacrocolpopexy and transvaginal mesh repairs offer comparable and lower failure rates than native tissue repair for vaginal vault prolapse.
  • All three surgical approaches provide sustained subjective benefits.
  • The study supports the safety and efficacy of mesh-augmented and native tissue repairs, with mesh augmentation showing better outcomes.